Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof
US11858993B2 · kind B2 · utility
0Cited by
24References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 13, 2021 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Mar 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are multi-specific binding agents that bind A33 and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. Also provided herein are methods of using multi-specific binding agents or compositions thereof for the detection, prevention, and/or therapeutic treatment of diseases characterized by expression of the A33 glycoprotein antigen, in particular, colorectal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.